FOXO3 and breast cancer: As mentioned earlier, nuclear accumulation of FOXO3a and hyper-active PI3K-AKT pathway as observed with acquisition of doxorubicin resistance in both doxorubicin-resistant breast cancer cell line and leukemic cell line (Hui et al., 2008a,b; Chen et al., 2010).